Robert Iannone is listed as a director on 1 SEC Form D filing by 1 issuer in Feb 2024: Autolus Therapeutics plc (London, United Kingdom (as filed: X0) — industry reported as "Other" — 2024; $200M reported sold to 1 investors).
What this means One deal on file with the SEC, filed Feb 2024. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Brent Rice (1 shared filing), Christian Itin (1 shared filing), Christopher Vann (1 shared filing), Cynthia Butitta (1 shared filing), David Brochu (1 shared filing) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 5 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Robert Iannone and found 1 difference: Same name, different state: "Robert Iannone" (MA) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.